ATLANTA, GA - An Atlanta-based medical device maker has raised more than half of a planned $1 million raise, according to a Securities & Exchange Commission filing.Scientific Intake has developed a weight loss product that helps people eat slower, thereby eating less.
People eat too quickly and eat too much before they feel full - or satisfied.
(more…)
CORAL GABLES, FL - Coral Gables-based Catalyst Pharmaceutical Partners Catalyst Pharmaceutical PartnersLatest from The Business JournalsFind out which South Florida stocks took the worst poundingCatalyst Pharmaceutical to sell 2.26M sharesCatalyst launches M clinical trialFollow this company said it plans to launch a $3.5 million stock offering, but its share price reacted negatively after the announcement.
The developmental-stage company (NASDAQ: CPRX) said it would sell 3.05 million shares of its common stock plus warrants to purchase an additional 1.52 million shares of its common stock. The price is $1.15 a share.
(more…)
WINSTOM-SALEM, NC - Cathtek, a medical device maker, is planning to relocate to the former Curly’s Harley-Davidson dealership on Reidsville Road in Winston-Salem.
The company, which is based in the Piedmont Triad Research Park in downtown, has applied to have the dealership property rezoned from highway business to general business, according to the Winston-Salem Journal.
(more…)
TAMPA, FL - The life sciences industry in Florida is flourishing, despite challenges.
That’s the message Dr. Michael Schmitt, life science analyst and editor of the Florida BioDatabase, brought to the inventors, investors and other life science professionals gathered in Tampa for the annual conference of BioFlorida.
There are 171 biotech companies in the state, up 26 percent since 2008, said Schmitt, citing new data he hadn’t yet had time to post on the database. About 25 percent of them are in the Tampa Bay area.
(more…)
Blacksburg, Virginia - Intrexon Corporation, a privately held synthetic biology company, today announced the acquisition of Immunologix, Inc., of Charleston, SC. Immunologix specializes in transforming naïve B-cells to produce 100% human monoclonal antibodies that can target all antigen types including, but not limited to cancer cells, viruses, bacteria, toxins, plus those epitopes related to autoimmune diseases such as diabetes, lupus, rheumatoid arthritis and multiple sclerosis. Terms of the transaction were not disclosed.
(more…)
ST. PETERSBURG, FL - IRX Therapeutics Inc. IRX Therapeutics Inc.Latest from The Business JournalsIRX Therapeutics comes home to Tampa Bay areaIRX Therapeutics raises million for cancer drug developmentFollow this company will relocate to St. Petersburg from New York by the end of the year.
The company said it would staff more than 280 positions within five years, at a projected minimum average wage of $90,000 annually. (more…)
MIAMI, FL - Opko Health Opko HealthLatest from The Business JournalsPhoto Gallery: Fast Tech AwardsForbes: 21 South Florida residents among America’s richestOpko sells ophthalmic instrument unit for .5MFollow this company has acquired Claros Diagnostics, a Woburn, Mass.-based company that has developed a novel blood testing kit for urology and infectious disease.
The Miami-based biotechnology and pharmaceutical company (NYSE: OPK) said Claros “presents an ideal strategic fit.”
Opko said it is developing unique antibody based tests for early diagnosis of Alzheimer’s disease; Parkinson’s disease; and lung, pancreatic and other cancers.
“The combined Opko-Claros technology will also provide an ideal platform for use as companion diagnostics,” the company stated.
Last month, Opko Health signed a deal to sell its ophthalmic instrumentation business to OPTOS for $17.5 million, plus future royalties.
Opko shares were down 13 cents to $4.68 in morning trading. The 52-week high was $5.03 on Feb. 16. The 52-week low was $2.41 on Oct. 18, 2010.
http://www.bizjournals.com/southflorida/news/2011/10/13/opko-acquires-claros-diagnostics.html?ed=2011-10-13&s=article_du&ana=e_du_pub
CHAPEL HILL, N.C. — Cempra Holdings, LLC, the parent holding company of Cempra Pharmaceuticals, Inc., today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) relating to its proposed initial public offering.
Stifel Nicolaus Weisel, Leerink Swann LLC and Cowen and Company are serving as joint book-running managers for the offering. Needham & Company, LLC is acting as co-manager.
http://www.prnewswire.com/news-releases/cempra-holdings-llc-files-registration-statement-for-proposed-initial-public-offering-131628393.html
SUNRISE, FL - Bioheart BioheartLatest from The Business JournalsHot LeadsBioheart terminates AnC Bio’s .6M investmentBioheart secures M investmentFollow this company announced a deal to raise $3 million by selling its common stock over the next two years.
The Sunrise-based development stage biotechnology company (OTCBB: BHRT) is working on clinical trials for its MyoCell product, a potential stem cell treatment for heart disease. It did not name the investor who agreed to buy its stock.
(more…)
